Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 3;20(7):28.
doi: 10.1007/s11882-020-00917-5.

Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020

Francesca Jaume  1 , Meritxell Valls-Mateus  2 , Joaquim Mullol  3   4   5
Affiliations
Review

Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020

Francesca Jaume et al. Curr Allergy Asthma Rep. .

Abstract

Purpose of review: The purposes of the review are as follows: (1) to define acute rhinosinusitis (ARS) and their phenotypes, (2) to highlight the ARS management according to international guidelines, (3) to compare the physicians' management with the ARS guideline recommendations, and (4) to report ARS socioeconomic burden.

Recent findings: Bacterial and non-bacterial ARS have similar symptoms, although they can be discriminated by using a combination of specific signs and symptoms. The prescription of antibiotics should be limited to clearly suspected bacterial ARS. There is an overuse of diagnosis tools and treatment prescriptions. The total cost per ARS episode in Europe is over €1000. ARS is mainly an inflammatory disease triggered by viral infection, and few cases end up developing bacterial infection. In most of the cases, it is a self-resolving disease which diagnosis is mainly clinical and the treatment symptomatic. The incidence of complications is low and independent of antibiotic use. There is a high socioeconomic burden associated to ARS.

Keywords: Acute rhinosinusitis; Bacterial acute rhinosinusitis; Common cold; Costs; EPOS; Respiratory tract infections.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Definition of ARS phenotype bases on EPOS 2020 Consensus. The duration of symptoms is used to differentiate viral ARS (common cold) from post-viral ARS, which is considered when the symptoms persist longer than 10 days or worsen after 5 days. Bacterial ARS should be suspected at any time when the presence of three or more of the sings or symptoms related to bacterial ARS are found
See this image and copyright information in PMC

References

    1. Fokkens W, Lund V, Hopkins HP, Kern R, Reitsma S, et al. EPOS2020: European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. - PubMed
    1. Stjärne P, Odebäck P, Ställberg B, Lundberg J, Olsson P. High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care. Primary Care Resp Journal. 2012;21:174–179. - PMC - PubMed
    1. Jaume F, Quintó L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study) BMJ Open. 2018;8(1):e018788. - PMC - PubMed
    1. Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(Suppl 1):S22–S209. - PubMed
    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:1–298. - PubMed